2,449
Views
39
CrossRef citations to date
0
Altmetric
Research Paper

MicroRNA-485-5p suppresses the proliferation, migration and invasion of small cell lung cancer cells by targeting flotillin-2

, , , , , , , & show all
Pages 1-12 | Received 07 May 2018, Accepted 15 Feb 2019, Published online: 05 Mar 2019

References

  • Mitsudomi T, Suda K, Yatabe Y. Surgery for NSCLC in the era of personalized medicine. Nat Rev Clin Oncol. 2013;10(4):235–244.
  • Lee JK, Hahn S, and Kim DW. Epidermal growth factor receptor tyrosine kinase inhibitors vs conventional chemotherapy in non-small cell lung cancer harboring wild-type epidermal growth factor receptor: a meta-analysis. JAMA. 2014, 311(14):1439–1437.
  • Spyratos D, Zarogoulidis P, Porpodis K, et al. Occupational exposure and lung cancer. J Thorac Dis. 2013, 5 Suppl 4: S440–5.
  • J. Liu, Huang W, Ren C, et al. Flotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-κB and PI3K/Akt3 signaling pathways. Sci Rep. 2015 Jul 24;5(11614). DOI:https://doi.org/10.1038/srep11614.
  • Gazdar AF, Bunn PA, Minna JD. Small-cell lung cancer: what we know, what we need to know and the path forward. Nat Rev Cancer. 2017;17(12):725–737.
  • Liu F, Bai C, Guo Z. The prognostic value of osteopontin in limited-stage small cell lung cancer patients and its mechanism. Oncotarget. 2017;8(41):70084–70096.
  • Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297.
  • Kim S, Kim M-J, Kim YJ, et al. Paclitaxel as third-line chemotherapy for small cell lung cancer failing both etoposide- and camptothecin-based chemotherapy. Medicine. 2017;96(42):e8176.
  • Mei Q, Li F, Quan H, et al. Busulfan inhibits growth of human osteosarcoma through miR-200 family microRNAs in vitro and in vivo. Cancer Sci. 2014;105(7):755–762.
  • Y. Chang, Zhao Y, Gu W, et al. Bufalin inhibits the differentiation and proliferation of cancer stem cells derived from primary osteosarcoma cells through Mir-148a. Cell Physiol Biochem. 2015;36(3):1186–1196.
  • Ji D, Li B, Shao Q, et al. MiR-22 suppresses BMP7 in the development of cirrhosis. Cell Physiol Biochem. 2015;36(3):1026–1036.
  • Song W, Li Q, Wang L, et al. Modulation of FoxO1 expression by miR-21 to promote growth of pancreatic ductal adenocarcinoma. Cell Physiol Biochem. 2015;35(1):184–190.
  • Wang Q, Cai J, Wang J, et al. MiR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion. Tumor Biol. 2014;35(12):12743–12748.
  • Di Leva G, Croce CM. MiRNA profiling of cancer. Curr Opin Genet Dev. 2013;23(1):3–11.
  • Cheng YX, Hu M, Chen L, et al. The mechanism of lipid raft mediating chemoresistance of cervical cancer. Saudi Med J. 2012;33(5):508–514.
  • Sonnino S, Prinetti A. Membrane domains and the “lipid raft” concept. Curr Med Chem. 2013;20(1):4–21.
  • George KS, Wu S. Lipid raft: A floating island of death or survival. Toxicol Appl Pharmacol. 2012;259(3):311–319.
  • Esquela-Kerscher A, Slack FJ. Oncomirs - MicroRNAs with a role in cancer. Nat Rev Cancer. 2006;6(4):259–269.
  • Valencia-Sanchez MA, Liu J, Hannon GJ, et al. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 2006;20(5):515–524.
  • H. Tang, Deng M, Tang Y, et al. MiR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression. Clin Cancer Res. 2013;19(20):5602–5612.
  • Solis GP, Hoegg M, Munderloh C, et al. Reggie/flotillin proteins are organized into stable tetramers in membrane microdomains. Biochem J. 2007;403:313–322. PMID:17206938. .
  • Ge L, Qi W, Wang LJ, et al. Flotillins play an essential role in Niemann-Pick C1-like 1-mediated cholesterol uptake. PNAS. 2011;108:551–556. PMID: 21187433. .
  • Langhorst MF, Reuter A, Stuermer CA. Scaffolding microdomains and beyond: the function of reggie/flotillin proteins. Cell Mol Life Sci. 2005;62:2228–2240. PMID:16091845.
  • Ludwig A, Otto GP, Riento K, et al. Flotillin microdomains interact with the cortical cytoskeleton to control uropod formation and neutrophil recruitment. J Cell Biol. 2010;191:771–781. PMID:21059848. .
  • Jennette J. Immunohistology in diagnostic pathology. Boca Raton, Florida: CRC Press Inc.; 1989.
  • Butz H, Szabó PM, Khella HW, et al. miRNA-target network reveals miR124as a key miRNA contributing to clear cellrenal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1. Oncotarget. 2015 May 20;6(14):12543–12557.
  • Wei G, Xu Y, Peng T, et al. miR-133 involves in lung adenocarcinoma cell metastasis by targeting FLOT2. Artif Cells Nanomed Biotechnol. 2018, 46(2):224–230.
  • Wang D, Lu G, Shao Y, et al. microRNA-802 inhibits epithelial-mesenchymal transition through targeting flotillin-2 in human prostate cancer. Biosci Rep. 2017 Apr 30;37(2):BSR20160521.
  • Pereira DM, Rodrigues PM, Borralho PM, et al. Delivering the promise of miRNA cancer therapeutics. Drug Discov Today. 2013;18(5–6):282–289.
  • Yu J, Wu SW, Wu WP. A tumor-suppressive microRNA, miRNA-485-5p, inhibits glioma cell proliferation and invasion by down-regulating TPD52L2. Am J Transl Res. 2017;9(7):3336–3344.
  • Huang R, Zheng Y, Li C, et al. MicroRNA-485-5p suppresses growth and metastasis in non-small cell lung cancer cells by targeting IGF2BP2. Life Sci. 2018;199:104–111.
  • Frick M, Bright NA, Riento K, et al. Coassembly of flotillins induces formation of membrane microdomains, membrane curvature, and vesicle budding. Curr Biol. 2007;17:1151–1156. PMID:21059848. .
  • Riento K, Frick M, Schafer I, et al. Endocytosis of flotillin-1 and flotillin-2 is regulated by Fyn kinase. J Cell Sci. 2009;122:912–918. PMID:19258392.
  • Nichols BJ. GM1-containing lipid rafts are depleted within clathrin-coated pits. Curr Biol. 2003;13:686–690. PMID:12699627.
  • Li R, Liu P, Wan Y, et al. A membrane microdomain-associated protein, arabidopsis Flot1, is involved in a clathrin-independent endocytic pathway and is required for downloaded by [Australian Catholic University] at 17:54 22 August 2017 14 seedling development. Plant Cell. 2012;24:2105–2122. PMID:22589463.
  • Y. Sun, Shen S, Tang H, et al. miR-429 identified by dynamic transcriptome analysis is a new candidate biomarker for colorectal cancer prognosis. OMICS. 2014;18(1):54–64.
  • Giordano S, Columbano A. MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? Hepatology. 2013;57(2):840–847.
  • X. Jiang, Huang H, Li Z, et al. miR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia. Proc Natl Acad Sci U S A. 2012;109(47):19397–19402.